Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Subst Abus. 2015 Apr 20;37(1):230–237. doi: 10.1080/08897077.2015.1028699

TABLE 2.

Available Levels of Care with Comparison by Adoption of AUD Pharmacotherapy

Full Sample
% (N)
Offers AUD Pharmacotherapy
% (N)
No AUD Pharmacotherapy
% (N)
χ2 Test
(Two Tailed)
Adult Services
Inpatient detoxification 13.2% (48) 24.7% (21) 8.8% (24) χ2 = 14.83, df = 1, p < .001
Inpatient treatment (<30 days) 10.5% (38) 14.1% (12) 9.2% (25) χ2 = 1.66, df = 1, p = .197
Residential (>30 days) 30.0% (109) 25.9% (22) 30.8% (84) χ2 = 0.74, df = 1, p = .389
Partial hospitalization 6.9% (25) 14.1% (12) 4.4% (12) χ2 = 9.60, df = 1, p = .002
Intensive outpatient 52.1% (189) 60.0% (51) 50.0% (136) χ2 = 2.60, df = 1, p = .107
Standard outpatient 70.1% (255) 70.6% (60) 70.3% (192) χ2 = 0.00, df = 1, p = .964
Adolescent-only Services
Inpatient treatment (<30 days) 1.1% (4) 1.2% (1) 1.1% (3) χ2 = 0.04, df = 1, p = .950
Residential (>30 days) 6.3% (23) 2.4% (2) 7.3% (20) χ2 = 2.76, df = 1, p = .097
Partial hospitalization 1.6% (6) 1.2% (1) 1.8% (5) χ2 = 0.17, df = 1, p = .684
Intensive outpatient 15.1% (55) 11.8% (10) 16.1% (44) χ2 = 0.94, df = 1, p = .333
Standard outpatient 31.4% (115) 29.4% (25) 32.0% (88) χ2 = 0.20, df = 1, p = .653

AUD, alcohol use disorder.